Minimally invasive fingerstick blood collection for therapeutic drug monitoring, stable at room temperature, ideal for home collection and mail-in testing.
Details:
Dry Blood Spot (DBS) Testing represents a revolutionary approach to therapeutic drug monitoring through minimally invasive fingerstick blood collection. This innovative method offers exceptional convenience for both patients and healthcare providers while maintaining the accuracy and reliability of traditional venipuncture blood testing.
What Makes DBS Unique
- Minimally Invasive: Simple fingerstick or heel prick requiring only 20-50 µL of blood
- Home Collection Capable: Patients can collect samples at home and mail to the lab
- Room Temperature Stable: Samples stable for weeks without refrigeration
- Cost-Effective Shipping: No cold-chain logistics required
- Reduced Biohazard Risk: Dried samples safer to handle and transport
- Long-Term Storage: Excellent stability for retrospective analysis
Ideal for Pain Management
DBS testing is particularly valuable in pain management settings where:
- Patients have limited mobility or transportation challenges
- Frequent monitoring of opioid medications is required (methadone, buprenorphine, fentanyl)
- Precise dosing adjustments are necessary to avoid respiratory depression or toxicity
- Detection of non-prescribed drug use or diversion is needed
- Patient compliance verification is essential for controlled substance prescribing
Applications
- Therapeutic Drug Monitoring for opioids and pain medications
- Monitoring of non-opioid analgesics (acetaminophen, NSAIDs, gabapentin)
- Compliance monitoring for controlled substance prescriptions
- Detection of drug diversion and non-prescribed substance use
Benefits
- Patient-friendly collection method
- Eliminates need for clinic visits for sample collection
- Suitable for patients with difficult venous access
- Long-term stability allows flexible sample collection timing
- Cost-effective compared to traditional blood draws
